Document Detail

Amiodarone in atrial fibrillation.
MedLine Citation:
PMID:  6524456     Owner:  NLM     Status:  MEDLINE    
Twenty-seven patients with atrial fibrillation without any concomitant conduction abnormality have been treated with oral amiodarone in a daily maintenance dose of 200 mg. The drug has been used for three purposes: 1) to block atrioventricular conduction, thereby decreasing the ventricular rate during atrial fibrillation (9 patients), 2) as prophylaxis against paroxysmal atrial fibrillation (8 patients), 3) as prophylaxis against recurrence of atrial fibrillation after DC conversion to sinus rhythm (13 patients). All patients were considered refractory to other antiarrhythmic drugs in these respects. In the second group, 4 of the 8 patients reported complete cessation of attacks and the others a marked reduction of the attack rate. In the third group, 10 of the 13 patients have maintained sinus rhythm for a longer period on treatment with amiodarone than with other drugs, resulting more than a triple prolongation of the time in sinus rhythm. In 3 patients the drug has been discontinued because of side-effects. In conclusion, amiodarone affords protection from episodes of paroxysmal atrial fibrillation, as well as from recurrence of atrial fibrillation after DC conversion to sinus rhythm. If the drug is ineffective in either of these respects, it may still be useful as a means of moderating the ventricular response in atrial fibrillation.
P Blomström; N Edvardsson; S B Olsson
Related Documents :
20361126 - Electrocardiographic markers for the early detection of cardiac disease in patients wit...
18771546 - Identification of unusual conditions after atrial septal defect repair by systematic tr...
4053716 - Unusual cardiac complications of wegener's granulomatosis.
6432116 - Graves' disease and atrial fibrillation: the case for even higher doses of therapeutic ...
21244736 - Nasal polyps: an independent risk factor for bronchial hyperresponsiveness in patients ...
21296316 - Effectiveness of the relative lymphocyte count to predict one-year mortality in patient...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Acta medica Scandinavica     Volume:  216     ISSN:  0001-6101     ISO Abbreviation:  Acta Med Scand     Publication Date:  1984  
Date Detail:
Created Date:  1985-02-27     Completed Date:  1985-02-27     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0370330     Medline TA:  Acta Med Scand     Country:  SWEDEN    
Other Details:
Languages:  eng     Pagination:  517-24     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amiodarone / administration & dosage,  therapeutic use*
Atrial Fibrillation / drug therapy*
Atrioventricular Node / drug effects
Benzofurans / therapeutic use*
Electric Countershock
Heart Rate / drug effects
Middle Aged
Reg. No./Substance:
0/Benzofurans; 1951-25-3/Amiodarone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Impaired left ventricular filling in young female diabetics. An echocardiographic study.
Next Document:  Leucopenia associated with beta-lactam antibiotic therapy.